David M. Knott’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

David M. Knott’s Portfolio APGNW Stock Details APGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$23K	Hold	2,000	–	–	0.01%	140
2021 Q2	$23K	Hold	2,000	–	–	0.01%	135
2021 Q1	$23K	Buy	+2,000	New	+$4.06K	0.01%	121

Other funds holding APGNW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

MIM

Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

David M. Knott's APGNW Position: Q3 2021 in Review

David M. Knott held its Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) position steady in Q3 2021 at 2,000 shares worth $23K. The position accounts for 0.01% of the portfolio, ranked #140.

David M. Knott first reported a position in APGNW in Q1 2021 and has held it in 3 quarters since. 11 funds tracked by Wall St. Rank hold APGNW as of Q3 2021.

David M. Knott held 2,000 shares of Apexigen, Inc. WarrantApexigen, Inc. Warrant worth $23K as of Q3 2021.
David M. Knott left its Apexigen, Inc. WarrantApexigen, Inc. Warrant share count unchanged in Q3 2021.
Apexigen, Inc. WarrantApexigen, Inc. Warrant made up 0.01% of David M. Knott's portfolio in Q3 2021, its #140 holding.
David M. Knott first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q1 2021 and has held it in 3 quarters since.
11 funds tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.